Combatting Diet Related Non-Communicable Diseases through Enhanced Surveillance

Imperial College London0 个研究点目标入组 200 人开始时间: 2023年10月24日最近更新: 2024年4月15日

适应症

试验速览

暂无简介。

•1. Male and Female aged 18-65 years old
•2. Individuals at high risk of developing a non-communicable disease assessed through the metabolic risk score:
•2.1. Overweight or obesity (BMI greater than 25 kg/m²) plus any two of the four factors:
•2.2. Raised triglycerides: = 100 mg/dL (1.7 mmol/L)
•2.3. Reduced HDL cholesterol: < 40 mg/dL (1.03 mmol/L) in males or < 50 mg/dL (1.29mmol/L) in females.
•2.4. Raised blood pressure: systolic BP = 130 or diastolic BP = 85 mm Hg.
•2.5. Raised fasting plasma glucose (FPG): = 90 mg/dL (5.0 mmol/L).
•3. Current smokers

•1. Suffer from the following conditions: type 2 diabetes, chronic gastrointestinal conditions (Crohn’s disease, irritable bowel syndrome, ulcerative colitis etc.), acute infectious diseases, cardiovascular diseases, hypertension, autoimmune conditions,
•2. Were on antibiotic treatment in the 12 weeks preceding enrolment of the clinical trial,
•3. Pregnant or currently breastfeeding,
•4. Are currently participating in other clinical trials or participated in another trial within the last 12 weeks,
•5. Require any medical interventions during the study period,
•6. Cannot give consent by yourself.

发起方